Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Short Communication

Lifetime Physical Activity and the Risk of Non-Hodgkin Lymphoma

Terry Boyle, Richard P. Gallagher, Randy D. Gascoyne, Joseph M. Connors, Nhu D. Le and John J. Spinelli
Terry Boyle
1Cancer Control Research, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
2School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada.
3Centre for Medical Research, The University of Western Australia, Perth, Western Australia, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tboyle@bccrc.ca
Richard P. Gallagher
1Cancer Control Research, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Randy D. Gascoyne
4Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph M. Connors
4Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nhu D. Le
1Cancer Control Research, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John J. Spinelli
1Cancer Control Research, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-14-1303 Published May 2015
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Research regarding the association between physical activity and the risk of non-Hodgkin lymphoma (NHL) is limited and inconsistent, and few studies have investigated whether the intensity and timing of physical activity influence the association. A case–control study of NHL was conducted in British Columbia, Canada, in 2000 to 2004. Data were collected on various NHL risk factors, including moderate-intensity and vigorous-intensity physical activity performed over the lifetime. Logistic regression was used to estimate the association between physical activity and the risk of NHL. This analysis included 818 controls and 749 cases. Lifetime vigorous-intensity physical activity was inversely associated with NHL risk. Participants in the second, third, and fourth quartiles of lifetime vigorous-intensity physical activity had an approximately 25% to 30% lower risk of NHL than those in the lowest quartile [adjusted odds ratios, 0.69 (95% confidence interval [CI], 0.52–0.93); 0.68 (95% CI, 0.50–0.92); and 0.75 (95% CI, 0.55–1.01), respectively]. No consistent associations were observed for total or moderate-intensity physical activity. There were no apparent age periods in which physical activity appeared to confer a greater risk reduction. In this study, we found that lifetime vigorous-intensity physical activity was associated with a significantly reduced risk of NHL. Given this finding, more research on physical activity intensity and timing in relation to NHL risk is warranted. Cancer Epidemiol Biomarkers Prev; 24(5); 873–7. ©2015 AACR.

Introduction

Non-Hodgkin lymphoma (NHL) accounted for approximately 3% of worldwide incident cancers in 2012 (1). NHL has few well-established risk factors, and little is known about its etiology (2). As such, the identification of modifiable risk factors is particularly important for the prevention and control of NHL (3).

Physical activity is convincingly associated with a reduced risk of several cancers, including colon, postmenopausal breast, and endometrial cancers (4). There is limited and inconsistent research regarding the association between physical activity and NHL risk; only 13 previous studies have investigated this association. Two recent meta-analyses of these studies indicate that people with the highest physical activity levels may have a slightly lower risk of NHL than people with the lowest physical activity levels (5, 6). Although there is no established etiologic pathway that explains how physical activity may reduce NHL risk, several plausible mechanisms have been suggested. Physical activity reduces obesity and increases immune function, both of which are hypothesized to play a role in NHL development (3, 5). Physical activity may also influence NHL risk by reducing inflammation, improving insulin sensitivity, and improving antioxidant defense systems (3, 5).

Research indicates that the intensity and timing of physical activity may influence the association between physical activity and cancer risk (7–9); however, few studies have investigated these issues in relation to NHL risk (5, 6). Only two studies have considered different levels of intensity when examining the association between physical activity and NHL risk, and there is limited research regarding the association between long-term or lifetime physical activity and NHL risk.

The aims of this study were to investigate the associations between (1) lifetime total, moderate-intensity, and vigorous-intensity physical activity and NHL risk; and (2) total, moderate-intensity, and vigorous-intensity recreational physical activity performed during specific age periods and NHL risk.

Materials and Methods

To investigate these aims, we used data from a case–control study that was conducted between 2000 and 2004 in British Columbia (BC), Canada (10). The study recruited 820 incident NHL cases (78.7% response rate) from the BC Cancer Registry and 848 randomly selected age group-, sex-, and residential location (Greater Vancouver Regional District or Capital Regional District) matched controls (45.7% response rate) from the Client Registry of the BC Ministry of Health. The Registry contains contact information for virtually the entire BC population, including all members of the mandatory provincial health insurance plan. All incident NHL cases were confirmed by a pathologist. NHL subtype was categorized as diffuse large B-cell lymphoma, follicular lymphoma, other B-cell lymphomas, and T-cell lymphomas (11).

A questionnaire (administered by self-report or computer-assisted telephone interview) was used to collect information about demographic characteristics and various possible NHL risk factors, including lifetime recreational physical activity. The study received approval from the BC Cancer Agency–University of BC Research Ethics Board. All participants gave written informed consent.

Assessment of physical activity

For each decade of life (i.e., 10–19 years, 20–29 years, and so on, to 70–79 years), participants were asked to record the average number of days/week and hours/day that they performed each of “mild,” “moderate,” and “vigorous” physical activity (see Supplementary Fig. S1). Participants were asked not to include job-related activities. “Mild” activities were defined as those that increase heart and breathing rates above resting level (example activities included gardening and heavy housework). Moderate activities were defined as those that increase heart rate moderately, and vigorous activities were defined as those that increase breathing and heart rates to a high level. No example moderate or vigorous activities were included on the questionnaire. A metabolic-equivalent (MET) value was assigned to each activity type (3.3, 4.0, and 8.0 for mild, moderate, and vigorous, respectively).

On the basis of these data, the average number of hours/week spent in each activity type in each age period was calculated. We then calculated the average MET-hours/week for each activity type in each age period by multiplying the average number of hours/week by the relevant MET value. These totals were summed to create a MET-hour/week total for each age period (i.e., mild plus moderate plus vigorous). We also combined the mild and moderate MET-hour/week totals to create a measure of moderate-“intensity” physical activity (i.e., activities with a MET value between 3 and 5.9), while the vigorous totals were considered to be a measure of vigorous-intensity physical activity (i.e., activities with a MET value of 6 or greater).

To investigate the association between lifetime physical activity and NHL risk, we calculated the average MET-hours/week over the lifetime for each of total, moderate-intensity, and vigorous-intensity physical activity, and then classified participants into quartiles, based on the distribution among controls. To investigate the association between NHL risk and physical activity in specific age periods, in each age period we classified participants into quartiles of total and moderate-intensity physical activity, based on the distribution among controls; and categorized participants as having done none or some vigorous-intensity physical activity.

Statistical analysis

Sixty participants were excluded due to large amounts of missing physical activity data, and a further 41 participants with missing ethnicity information were excluded, leaving 1,567 participants (818 controls and 749 cases) in this analysis.

Logistic regression was used to estimate the association between physical activity and NHL risk, and multinomial logistic regression was used to determine whether the association between physical activity and NHL risk differed by NHL subtype.

The frequency-matching variables (age group, sex, and residential location) were included as covariates in all analyses. A directed acyclic graph (causal diagram) was used to inform the choice of other covariates (12). The following known or possible NHL risk factors were included on the causal diagram: alcohol consumption, autoimmune disorders, educational attainment (as a proxy for socioeconomic status), energy intake, ethnicity, family history of NHL, immune function, obesity, smoking, sun exposure, and vitamin D intake (see Supplementary Fig. S1). Associations between these variables, and the direction of the associations, were based on the published literature. Immune function, sun exposure, and obesity were assumed to be on the causal pathway. Ethnicity, educational attainment, and autoimmune disease were identified as a minimal sufficient set of confounders, and a model containing these three variables and the frequency-matching variables was considered the “fully-adjusted” model. To increase precision, we then used the backward deletion strategy to remove confounders until the change-in-estimate from the “fully adjusted” model was greater than 5% (13). Ethnicity (along with the frequency-matching variables) was the only covariate that remained in the model following this procedure. Moderate-intensity and vigorous-intensity physical activity were mutually adjusted. Trend tests were conducted by entering the relevant ordinal variable into the model as a continuous variable.

We tested for nonlinearity in the associations between NHL risk and lifetime total, moderate-intensity, and vigorous-intensity physical activity using fractional polynomial regression, with the exposure variables entered into “fully adjusted” models as continuous MET-hours/week variables. There was no significant evidence that any of these associations were nonlinear (i.e., models including first- or second-degree fractional polynomials were not a significantly better fit than linear models). A significance level of P = 0.05 was used in all analyses. All analyses were performed using Stata 13.1 (StataCorp).

Results

Demographic characteristics of the participants are shown in Table 1. Cases were more likely than controls to be male, be in an older age group, live in the Greater Vancouver Regional District, to have not completed high school, and to have had autoimmune disease. The distribution of the lifetime physical activity variables by sex and NHL subtype is shown in Supplementary Table S1.

View this table:
  • View inline
  • View popup
Table 1.

Characteristics of the participants in a case–control study of NHL, British Columbia, Canada, 2000–2004

There was no clear association between lifetime total physical activity (lifetime average MET-hours/week) and overall NHL risk, and lifetime moderate-intensity physical activity did not appear to be associated with NHL risk (Table 2). For lifetime vigorous-intensity physical activity, participants in the second, third, and fourth quartiles of average MET-hours/week had an approximately 25% to 30% lower risk of NHL than those in the lowest quartile [adjusted odds ratios, 0.69; 95% confidence interval (CI), 0.52–0.93; 0.68; 95% CI, 0.50–0.92; and 0.75; 95% CI, 0.55–1.01, for the second, third, and fourth quartiles respectively; PTrend = 0.072]. An inverse association between lifetime vigorous-intensity physical activity and overall NHL risk was observed in both males and female, although among males the largest risk reduction was found in the second and third quartiles, while in females the greatest risk reduction was observed in the highest quartile (PTrend = 0.228 and 0.144 for males and females, respectively).

View this table:
  • View inline
  • View popup
Table 2.

Associations between lifetime total, moderate-intensity, and vigorous-intensity physical activity and the risk of NHL in a case–control study conducted in British Columbia, Canada, 2000–2004

For lifetime vigorous-intensity physical activity, an inverse association was observed for all NHL subtypes (Table 3). Stronger associations were observed for follicular lymphoma and other B-cell lymphomas than for diffuse large B-cell lymphoma and T-cell lymphoma; however, these differences were not statistically significant. Neither lifetime total nor moderate-intensity physical activity was associated with the risk of any NHL subtype.

View this table:
  • View inline
  • View popup
Table 3.

Associations between lifetime total, moderate-intensity, and vigorous-intensity physical activity and the risk of NHL subtypes in a case–control study conducted in British Columbia, Canada, 2000–2004

There were no specific age periods in which physical activity appeared to confer a greater risk reduction (Supplementary Tables S2 and S3).

Discussion

In this study, we found that vigorous-intensity lifetime physical activity was associated with a significantly reduced risk of NHL. An inverse association was seen in both males and females and for all NHL subtypes. No consistent associations were observed between NHL risk and total or moderate-intensity physical activity.

We found that lifetime vigorous-intensity physical activity was more strongly associated with NHL risk than moderate-intensity physical activity or physical activity in any specific age period. Only one previous study has examined lifetime non-occupational physical activity in relation to NHL risk, with the results indicating no association (14). In regard to physical activity intensity, although it is possible that vigorous-intensity physical activity is required to reduce NHL risk, another explanation is that measures of vigorous-intensity physical activity are better able to distinguish between active and inactive participants. Measures of vigorous-intensity physical activity are more reliable than measures of moderate-intensity physical activity (15), so may result in less exposure misclassification. Only two previous studies have considered different intensity levels when examining the association between physical activity and NHL risk (16, 17). One study found a slightly stronger inverse association for vigorous-intensity physical activity than for moderate-intensity physical activity (16), while the other found the opposite for females and no difference for males (17). There are too little data to draw any firm conclusions regarding whether intensity and/or timing influence the association between physical activity and NHL risk.

In NHL subtype analyses, we found a stronger association for physical activity and the risk of follicular lymphoma and other B-cell lymphomas than for diffuse large B-cell lymphoma and T-cell lymphoma, although these differences were not statistically significant. Although two studies have found that physical activity may have a greater influence on follicular lymphoma risk than diffuse large B-cell lymphoma risk (17, 18), most studies have found little variation between physical activity and the risk of different NHL subtypes (14, 16, 19–23). It remains unclear whether the association between physical activity and NHL risk varies by subtype.

This study had several limitations that should be considered. First, the validity and reliability of the physical activity questionnaire is unknown, although the questions are similar to those in widely used questionnaires used to measure recent physical activity (24). While research indicates that physical activity performed in the past can be recalled reliably (15, 25), asking participants about their physical activity levels in early adulthood is likely to result in some exposure misclassification. This exposure misclassification was likely to have been nondifferential, so any possible bias was likely to have been in the direction of the null. Second, the low response rate among controls means we cannot rule out selection bias as a possible explanation for the observed results. It is possible that controls who participated in the study were more physically active than nonparticipants, so we may have overestimated the possible inverse association between physical activity and NHL risk. Another possible explanation for the results is recall bias. Physical activity is not a well-known risk factor for NHL, so recall bias is unlikely to have had a large influence; however, we cannot rule it out as an explanation.

In conclusion, in this case–control study, we found that lifetime vigorous-intensity physical activity was associated with a significantly reduced risk of NHL. Given this finding, more research on physical activity intensity and timing in relation to NHL risk is warranted.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Authors' Contributions

Conception and design: R.P. Gallagher, J.J. Spinelli

Development of methodology: R.P. Gallagher, J.J. Spinelli

Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.): R.P. Gallagher, R.D. Gascoyne, J.M. Connors, J.J. Spinelli

Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis): T. Boyle, J.M. Connors, N.D. Le, J.J. Spinelli

Writing, review, and/or revision of the manuscript: T. Boyle, R.P. Gallagher, R.D. Gascoyne, J.M. Connors, N.D. Le, J.J. Spinelli

Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases): R.P. Gallagher

Study supervision: R.P. Gallagher, J.J. Spinelli

Grant Support

This study was supported by the National Cancer Institute of Canada (grant to R.P. Gallagher, R.D. Gascoyne, J.M. Connors, N.D. Le, and J.J. Spinelli), the Canadian Institutes of Health Research (grant to R.P. Gallagher, R.D. Gascoyne, J.M. Connors, N.D. Le, and J.J. Spinelli; fellowship #300068 to T. Boyle), the Michael Smith Foundation for Health Research (Postdoctoral Fellowship #5553 to T. Boyle), The University of British Columbia (Honorary Killam Postdoctoral Research Fellowship to T. Boyle), and the Australian National Health and Medical Research Council (Early Career Fellowship #1072266 to T. Boyle).

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Acknowledgments

The authors thank Agnes Lai and Zenaida Abanto (Cancer Control Research, British Columbia Cancer Agency) for their contributions to this study.

Footnotes

  • Note: Supplementary data for this article are available at Cancer Epidemiology, Biomarkers & Prevention Online (http://cebp.aacrjournals.org/).

  • Received November 19, 2014.
  • Revision received February 3, 2015.
  • Accepted February 16, 2015.
  • ©2015 American Association for Cancer Research.

References

  1. 1.↵
    1. Ferlay J,
    2. Soerjomataram I,
    3. Ervik M,
    4. Dikshit R,
    5. Eser S,
    6. Mathers C,
    7. et al.
    Globocan 2012 v1.0, cancer incidence and mortality worldwide: IARC Cancerbase no. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013.
  2. 2.↵
    1. Adami H-O,
    2. Hunter D,
    3. Trichopoulos D
    1. Melbye M,
    2. Smedby KE,
    3. Trichopoulos D
    . Non-Hodgkin lymphoma. In: Adami H-O, Hunter D, Trichopoulos D , editors. Textbook of cancer epidemiology. 2nd ed. Oxford: Oxford University Press; 2008. p. 669–93.
  3. 3.↵
    1. Courneya KS,
    2. Friedenreich CM
    1. Pan SY,
    2. Morrison H
    . Physical activity and hematologic cancer prevention. In: Courneya KS, Friedenreich CM , editors. Physical activity and cancer. Berlin/Heidelberg: Springer 2011. p. 135–58.
  4. 4.↵
    1. Friedenreich CM,
    2. Neilson HK,
    3. Lynch BM
    . State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer 2010;46:2593–604.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Jochem C,
    2. Leitzmann MF,
    3. Keimling M,
    4. Schmid D,
    5. Behrens G
    . Physical activity in relation to risk of hematologic cancers: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2014;23:833–46.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Vermaete NVH,
    2. Wolter P,
    3. Verhoef GEG,
    4. Kollen BJ,
    5. Kwakkel G,
    6. Schepers L,
    7. et al.
    Physical activity and risk of lymphoma: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2013;22:1173–84.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Boyle T
    . Physical activity and colon cancer: timing, intensity and sedentary behavior. Am J Lifestyle Med 2012;6:204–15.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Friedenreich CM,
    2. Cust AE
    . Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects. Br J Sports Med 2008;42:636–47.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Courneya KS,
    2. Friedenreich CM
    1. Cust AE
    . Physical activity and gynecologic cancer prevention. In: Courneya KS, Friedenreich CM , editors. Physical activity and cancer: Berlin/Heidelberg: Springer; 2011. p. 159–85.
  10. 10.↵
    1. Spinelli JJ,
    2. Ng CH,
    3. Weber JP,
    4. Connors JM,
    5. Gascoyne RD,
    6. Lai AS,
    7. et al.
    Organochlorines and risk of non-Hodgkin lymphoma. Int J Cancer 2007;121:2767–75.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Jaffe ES,
    2. Harris N,
    3. Stein H,
    4. JW V
    . World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001.
  12. 12.↵
    1. Textor J,
    2. Hardt J,
    3. Knüppel S
    . Dagitty: a graphical tool for analyzing causal diagrams. Epidemiology 2011;22:745.
    OpenUrlPubMed
  13. 13.↵
    1. Rothman KJ,
    2. Greenland S,
    3. Lash TL
    . Modern epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
  14. 14.↵
    1. Lu Y,
    2. Prescott J,
    3. Sullivan-Halley J,
    4. Henderson KD,
    5. Ma H,
    6. Chang ET,
    7. et al.
    Body size, recreational physical activity, and B-cell non-Hodgkin lymphoma risk among women in the California Teachers Study. Am J Epidemiol 2009;170:1231–40.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Friedenreich CM,
    2. Courneya KS,
    3. Bryant HE
    . The lifetime total physical activity questionnaire: development and reliability. Med Sci Sports Exerc 1998;30:266–74.
    OpenUrlPubMed
  16. 16.↵
    1. Cerhan J,
    2. Bernstein L,
    3. Severson R,
    4. Davis S,
    5. Colt J,
    6. Blair A,
    7. et al.
    Anthropometrics, physical activity, related medical conditions, and the risk of non-Hodgkin lymphoma. Cancer Causes Control 2005;16:1203–14.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Pan SY,
    2. Mao Y,
    3. Ugnat A-M,
    4. Canadian Cancer Registries Epidemiology Research Group
    . Physical activity, obesity, energy intake, and the risk of non-Hodgkin's lymphoma: a population-based case–control study. Am J Epidemiol 2005;162:1162–73.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Cerhan JR,
    2. Janney CA,
    3. Vachon CM,
    4. Habermann TM,
    5. Kay NE,
    6. Potter JD,
    7. et al.
    Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study. Am J Epidemiol 2002;156:527–35.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Kabat GC,
    2. Kim MY,
    3. Jean Wactawski W,
    4. Bea JW,
    5. Edlefsen KL,
    6. Adams-Campbell LL,
    7. et al.
    Anthropometric factors, physical activity, and risk of non-Hodgkin's lymphoma in the women's health initiative. Cancer Epidemiology 2012;36:52–9.
    OpenUrlPubMed
  20. 20.↵
    1. Kelly JL,
    2. Fredericksen ZS,
    3. Liebow M,
    4. Shanafelt TD,
    5. Thompson CA,
    6. Call TG,
    7. et al.
    The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender. Ann Epidemiol 2012;22:855–62.
    OpenUrlPubMed
  21. 21.↵
    1. Lim U,
    2. Morton LM,
    3. Subar AF,
    4. Baris D,
    5. Stolzenberg-Solomon R,
    6. Leitzmann M,
    7. et al.
    Alcohol, smoking, and body size in relation to incident Hodgkin's and non-Hodgkin's lymphoma risk. Am J Epidemiol 2007;166:697–708.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Teras LR,
    2. Gapstur SM,
    3. Diver WR,
    4. Birmann BM,
    5. Patel AV
    . Recreational physical activity, leisure sitting time and risk of non-Hodgkin lymphoid neoplasms in the American Cancer Society Cancer Prevention Study II cohort. Int J Cancer 2012;131:1912–20.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. van Veldhoven CM,
    2. Khan AE,
    3. Teucher B,
    4. Rohrmann S,
    5. Raaschou-Nielsen O,
    6. Tjonneland A,
    7. et al.
    Physical activity and lymphoid neoplasms in the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Cancer 2011;47:748–60.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Craig CL,
    2. Marshall AL,
    3. Sjostrom M,
    4. Bauman AE,
    5. Booth ML,
    6. Ainsworth BE,
    7. et al.
    International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381–95.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Boyle T,
    2. Heyworth J,
    3. Bull F,
    4. Fritschi L
    . Test–retest reliability of transport-related physical activity performed over the lifetime. J Phys Act Health 2013;10:626–31.
    OpenUrlPubMed
View Abstract
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 24 (5)
May 2015
Volume 24, Issue 5
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Lifetime Physical Activity and the Risk of Non-Hodgkin Lymphoma
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Lifetime Physical Activity and the Risk of Non-Hodgkin Lymphoma
Terry Boyle, Richard P. Gallagher, Randy D. Gascoyne, Joseph M. Connors, Nhu D. Le and John J. Spinelli
Cancer Epidemiol Biomarkers Prev May 1 2015 (24) (5) 873-877; DOI: 10.1158/1055-9965.EPI-14-1303

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Lifetime Physical Activity and the Risk of Non-Hodgkin Lymphoma
Terry Boyle, Richard P. Gallagher, Randy D. Gascoyne, Joseph M. Connors, Nhu D. Le and John J. Spinelli
Cancer Epidemiol Biomarkers Prev May 1 2015 (24) (5) 873-877; DOI: 10.1158/1055-9965.EPI-14-1303
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Common Variants in High-Risk Pancreatic Cancer Patients
  • Colorectal Cancer Screening Among Asian Americans
  • Quality of Online Cancer-Related Clinical Trial Information
Show more Short Communication
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement